相关实验视频

Updated: Jul 23, 2025

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients

Published on: November 19, 2019

宫小细胞神经内分泌癌:从分子基础到治疗进展

Angel Chao¹, Ren-Chin Wu², Chiao-Yun Lin¹

¹Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan; Gynecologic Cancer Research Center, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan.

Biomedical journal

|July 19, 2023

概括

宫小细胞神经内分泌癌 (SCNECC) 是一种侵袭性癌症,通常与HPV有关. 免疫检查点抑制剂在改善SCNECC患者治疗结果方面表现有前途.

科学领域:

妇科瘤学妇科瘤学
在瘤学瘤学.
病理学病理学病理学

背景情况:

宫小细胞神经内分泌癌 (SCNECC) 是一种罕见的,侵袭性的子宫恶性瘤.
人类乳头瘤病毒 (HPV) 感染是SCNECC的常见原因.
有限的临床试验和基于证据的指导方针带来了治疗挑战.

研究的目的:

审查目前对SCNECC的理解.
探索免疫检查点抑制剂 (ICI) 在SCNECC治疗中的潜力.
突出进一步研究和合作努力的需要.

主要方法:

审查现有文献,包括案例系列和报告.
对免疫检查点抑制剂 (ICI) 在相关癌症中的疗效进行分析.
讨论SCNECC的潜在治疗策略.

主要成果:

在目前的治疗方法下,SCNECC的预后仍然很差.
ICI已经在扩展阶段的小细胞神经内分泌肺癌中表现出有效性.
布罗利祖马布在与HPV相关的非SCNE宫癌中表现出好处.

结论:

将ICI与化学辐射相结合可能会改善SCNECC的结果.
对SCNECC生物学,基因组异常和分子标的进一步研究至关重要.
建立一个特定于SCNECC的生物库对于未来的药物开发和合作努力至关重要.

关键词:

免疫检查点抑制剂免疫检查点抑制剂分子目标是分子目标.小细胞神经内分泌癌瘤宫子宫的子宫.

更多相关视频

Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids

Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids

Published on: October 14, 2019

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...